CBD Leads to Nonseizure Improvements, AbbVie Launches 24-Hour Levodopa Infusion in EU, CNM-Au8 Improves Visual Function and Cognition

WATCH TIME: 4 minutes Welcome to this special edition of Neurology News Network. I’m Marco Meglio. In a survey study of patients with either Lennox-Gastaut syndrome or Dravet syndrome, findings showed that treatment with add-on cannabidiol (CBD; Epidiolex) led to improvements in nonseizure outcomes, regardless of reduction in seizure frequency. ... Read More

CBD Provides Symptom Relief and Improvement in Gastroparesis

Pharmaceutical-grade cannabidiol (CBD) relieved symptoms in patients with idiopathic and diabetic gastroparesis and increased tolerance of liquid nutrient intake after 4 weeks of treatment in a phase 2 randomized double-blinded, placebo-controlled study recently published in Clinical Gastroenterology and Hepatology. There is “significant unmet medical need in gastroparesis,” and compared with cannabis, which has ... Read More

Your Quick and Easy Guide to Medical Marijuana Evaluations

Sponsored Content There is a medical marijuana program in over three-quarters of American states. You’ll generally find many similarities in the application process across the board. However, it’s essential to note that there are also several important differences. For example, certain states still forbid completing an online MMJ evaluation. As ... Read More